CPAP devices co-designed by Mercedes AMG’s High Performance Powertrains operation have now been delivered to NHS hospitals, with over 3,000 requests for the designs, across over 100 countries.
The breathing aid, dubbed UCL-Ventura, assists patients suffering from the COVID-19 coronavirus, and was co-designed by engineers at HPP and University College London.
After the design was reverse-engineered it took less than 100 hours to produce the first device, following which it underwent evaluations at UCL Hospital in London and at other sister medical facilities.
The device was approved by the necessary regulators and a batch of 10,000 were ordered by the UK government.
The devices were then manufactured at Mercedes-AMG HPP in Brixworth, with 40 machines normally used to produce F1 pistons and turbocharged repurposed in order to make the CPAP devices.
All of the details required to make the device were made available free of charge, including the blueprints for the design, as well as the materials, tools and kits needed for the process.
It has been revealed that there have been over 3,100 requests for the designs, and over 1,800 teams have been approved and had the designs shared, across 105 countries.
“It is exceptionally pleasing to see that the flow devices swiftly engineered and produced in volume here at Brixworth are helping patients around the UK, said Mercedes AMG HPP Managing Director Andy Cowell.
“The supply of devices to the local Northampton hospital engendered a great sense of pride for the whole team.”
